Sera Prognostics, Inc.
Key Metrics
- Previous Close
- $2.00
- 52-Week Range
- $1.56 – $3.85
- Market Cap
- $75.96M
- P/E (TTM)
- —
- EPS (TTM)
- -0.67
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.45
- PEG Ratio
- —
- Return on Equity
- -49.73%
- Return on Assets
- -24.72%
- Gross Margin
- -103.13%
- Operating Margin
- -38755.21%
- Profit Margin
- 0.00%
- Current Ratio
- 1.88
- Debt/Equity
- 0.06
- Total Debt
- $3.27M
- Free Cash Flow
- $-19.17M
- Revenue Growth
- 162.50%
- Earnings Growth
- —
- Enterprise Value
- $35.14M
Market Snapshot
About
Sera Prognostics, Inc. is a women's health diagnostic company dedicated to improving maternal and neonatal health. The company develops and commercializes innovative proteomics-based tests to predict pregnancy complications, including preterm birth risk assessment. Sera Prognostics aims to provide healthcare providers with actionable insights to guide prenatal care decisions.